Search research articles
Contact Us
Filters
Showing results (31-40 of 211) with videos related to
Page
of 22
Sort By:
Frontiers in Immunology
|
May 2, 2022
Association Between Baseline Therapy and Flare Reduction in Mepolizumab-Treated Patients With Hypereosinophilic Syndrome
Andreas Reiter, Guillaume Lefevre, Maria C Cid, et al.
Haematologica
|
March 30, 2013
Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V
Karoline V Gleixner, Barbara Peter, Katharina Blatt, et al.
Onkologie
|
October 10, 2006
Leukocytoclastic vasculitis and acute renal failure after influenza vaccination in an elderly patient with myelodysplastic syndrome
Silke Ulm, Margit Hummel, Michael Emig, et al.
Expert Review of Hematology
|
August 30, 2014
The serum tryptase test: an emerging robust biomarker in clinical hematology
Peter Valent, Wolfgang R Sperr, Karl Sotlar, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 4, 2025
KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic Mastocytosis
Andreas Reiter, Julien Rossignol, Michael W Deininger, et al.
Archives of Orthopaedic and Trauma Surgery
|
September 17, 2008
Ulnar shortening after TFCC suture repair of Palmer type 1B lesions
Maya B Wolf, Markus W Kroeber, Andreas Reiter, et al.
Genes, Chromosomes & Cancer
|
March 25, 2026
Myeloid Neoplasms With a t(5;12)(q31;p13) and an Associated ETV6::ACSL6 Gene Fusion Are Diagnostically Challenging and Have a Poor Prognosis
Bettina Balk, Marietta Truger, Wencke Walter, et al.
American Journal of Hematology
|
June 7, 2023
The international consensus classification of eosinophilic disorders and systemic mastocytosis
Sa A Wang, Attilio Orazi, Jason Gotlib, et al.
Annals of Hematology
|
March 26, 2013
Effects of imatinib mesylate in patients with polycythemia vera: results of a phase II study
Kirsten Merx, Alice Fabarius, Philipp Erben, et al.
Haematologica
|
October 3, 2009
TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals
Andrew Chase, Thomas Ernst, Andreas Fiebig, et al.
Page
of 22
Search research articles
Search
Showing results (31-40 of 211) with videos related to
Sort By:
Page
of 22
Frontiers in Immunology
|
May 2, 2022
Association Between Baseline Therapy and Flare Reduction in Mepolizumab-Treated Patients With Hypereosinophilic Syndrome
Andreas Reiter, Guillaume Lefevre, Maria C Cid, et al.
Haematologica
|
March 30, 2013
Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V
Karoline V Gleixner, Barbara Peter, Katharina Blatt, et al.
Onkologie
|
October 10, 2006
Leukocytoclastic vasculitis and acute renal failure after influenza vaccination in an elderly patient with myelodysplastic syndrome
Silke Ulm, Margit Hummel, Michael Emig, et al.
Expert Review of Hematology
|
August 30, 2014
The serum tryptase test: an emerging robust biomarker in clinical hematology
Peter Valent, Wolfgang R Sperr, Karl Sotlar, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
November 4, 2025
KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic Mastocytosis
Andreas Reiter, Julien Rossignol, Michael W Deininger, et al.
Archives of Orthopaedic and Trauma Surgery
|
September 17, 2008
Ulnar shortening after TFCC suture repair of Palmer type 1B lesions
Maya B Wolf, Markus W Kroeber, Andreas Reiter, et al.
Genes, Chromosomes & Cancer
|
March 25, 2026
Myeloid Neoplasms With a t(5;12)(q31;p13) and an Associated ETV6::ACSL6 Gene Fusion Are Diagnostically Challenging and Have a Poor Prognosis
Bettina Balk, Marietta Truger, Wencke Walter, et al.
American Journal of Hematology
|
June 7, 2023
The international consensus classification of eosinophilic disorders and systemic mastocytosis
Sa A Wang, Attilio Orazi, Jason Gotlib, et al.
Annals of Hematology
|
March 26, 2013
Effects of imatinib mesylate in patients with polycythemia vera: results of a phase II study
Kirsten Merx, Alice Fabarius, Philipp Erben, et al.
Haematologica
|
October 3, 2009
TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals
Andrew Chase, Thomas Ernst, Andreas Fiebig, et al.
Page
of 22